---
_schema: default
id: 104596
date: 2024-12-08
title: >-
    What is Tardive Dyskinesia and how can it be prevented or treated?
article_title: >-
    What is Tardive Dyskinesia and how can it be prevented or treated?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Medicine
  page_description: >-
    Tardive Dyskinesia (TD) is a movement disorder caused primarily by long-term use of antipsychotic medications, characterized by involuntary body movements. This content discusses its causes, prevention strategies, and treatment options available for managing symptoms.
  page_keywords: >-
    Tardive Dyskinesia, TD, movement disorder, involuntary movements, antipsychotic medications, dopamine receptors, treatment, prevention, risk factors, schizophrenia, bipolar disorder, medication management, symptom management, Ingrezza, Austedo, supportive therapies, occupational therapy
author: QuickTakes
question: >-
    What is Tardive Dyskinesia and how can it be prevented or treated?
answer: >-
    Tardive dyskinesia (TD) is a movement disorder characterized by involuntary, repetitive body movements, which can include grimacing, tongue protrusion, lip smacking, and other abnormal facial movements. It is primarily associated with the long-term use of antipsychotic medications, particularly those that block dopamine receptors, such as first- and second-generation antipsychotics. TD can also occur with other medications, such as metoclopramide and prochlorperazine.\n\n### Causes and Risk Factors\nTD is most commonly seen in individuals with schizophrenia and bipolar disorder who are treated with antipsychotic medications. However, it can develop in any patient receiving dopamine-blocking agents, especially those with developmental disabilities. Symptoms may begin as early as 3 to 6 months after starting treatment, and the disorder can significantly interfere with daily functioning in about 20% of affected individuals.\n\n### Prevention\nPreventing tardive dyskinesia primarily involves careful management of antipsychotic treatment. Strategies include:\n- **Using the lowest effective dose** of antipsychotic medications.\n- **Regular monitoring** for early signs of TD, especially in high-risk populations.\n- **Considering alternative medications** that have a lower risk of inducing TD.\n\n### Treatment\nWhile there is currently no definitive cure for tardive dyskinesia, several treatment options may help manage symptoms:\n- **Medication adjustments**: Reducing the dose or discontinuing the antipsychotic medication may alleviate symptoms, although this is not always effective.\n- **Newer medications**: Drugs like Ingrezza (valbenazine) and Austedo (deutetrabenazine) have been approved specifically for the treatment of TD and may help reduce symptoms.\n- **Supportive therapies**: Occupational therapy and counseling can assist patients in coping with the functional impacts of TD.\n\n### Conclusion\nTardive dyskinesia is a serious side effect of antipsychotic medications that can lead to significant distress and impairment. Awareness of its symptoms, risk factors, and management strategies is crucial for healthcare providers to minimize its occurrence and impact on patients' lives. Regular follow-up and a proactive approach to medication management are essential in preventing and treating this condition.
subject: Medicine
file_name: what-is-tardive-dyskinesia-and-how-can-it-be-prevented-or-treated.md
url: /learn/medicine/questions/what-is-tardive-dyskinesia-and-how-can-it-be-prevented-or-treated
score: -1.0
related_article1:
    id: 104607
    title: >-
        How do Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) differ from SSRIs?
    subject: Medicine
    url: /learn/medicine/questions/how-do-serotoninnorepinephrine-reuptake-inhibitors-snri-differ-from-ssris
related_article2:
    id: 104600
    title: >-
        How do benzodiazepines work to alleviate anxiety symptoms?
    subject: Medicine
    url: /learn/medicine/questions/how-do-benzodiazepines-work-to-alleviate-anxiety-symptoms
related_article3:
    id: 104591
    title: >-
        How do phenothiazines differ from nonphenothiazines in terms of chemical structure and effects?
    subject: Medicine
    url: /learn/medicine/questions/how-do-phenothiazines-differ-from-nonphenothiazines-in-terms-of-chemical-structure-and-effects
related_article4:
    id: 104617
    title: >-
        What are the latest advancements in the development of antipsychotics and anxiolytics?
    subject: Medicine
    url: /learn/medicine/questions/what-are-the-latest-advancements-in-the-development-of-antipsychotics-and-anxiolytics
related_article5:
    id: 104612
    title: >-
        How can nonadherence to antidepressant treatment be addressed in patients?
    subject: Health Studies
    url: /learn/health-studies/questions/how-can-nonadherence-to-antidepressant-treatment-be-addressed-in-patients
---

&nbsp;